Fidaxomicin - the new drug for Clostridium difficile infection

Por Vaishnavi, Chetana
Publicado no Indian J Med Res (2015)

Characterization of biofilms in biliary stents and potential factors involved in occlusion

Por Vaishnavi, Chetana, Samanta, Jayanta, Kochhar, Rakesh
Publicado no World J Gastroenterol (2018)

Toxinotyping and Sequencing of Clostridium difficile Isolates from Patients in a Tertiary Care Hospital of Northern India

Por Singh, Meenakshi, Vaishnavi, Chetana, Mahmood, Safrun, Kochhar, Rakesh
Publicado no Front Med (Lausanne) (2017)

Toxigenic Clostridium difficile isolates from clinically significant diarrhoea in patients from a tertiary care centre

Por Singh, Meenakshi, Vaishnavi, Chetana, Kochhar, Rakesh, Mahmood, Safrun
Publicado no Indian J Med Res (2017)

Effect of Lactobacillus acidophilus & epidermal growth factor on experimentally induced Clostridium difficile infection

Por Kaur, Sukhminderjit, Vaishnavi, Chetana, Prasad, Kaushal Kishor, Ray, Pallab, Kochhar, Rakesh
Publicado em 2011

In Vitro and In Vivo Activities of the Novel Ketolide RBx 14255 against Clostridium difficile

Por Kumar, Manoj, Mathur, Tarun, Barman, Tarani K., Ramkumar, G., Bhati, Ashish, Shukla, Gunjan, Kalia, Vandana, Pandya, Manisha, Raj, V. Samuel, Upadhyay, Dilip J., Vaishnavi, Chetana, Chakrabarti, Anjan, Das, Biswajit, Bhatnagar, Pradip K.
Publicado em 2012